Desmopressin

CAS: 16679-58-6

Ref. 3D-FD110210

Product Information

• Name: Desmopressin
• Synonyms: 1-(3-Mercaptopropanoic acid)-8-D-argininevasopressin, 1-{[(4R,7S,10S,13S,16S)-7-(2-Amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-L-arginylglycinamide, 16679-58-6, 240-726-7, glycinamide, 1-[[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-yl]carbonyl]-L-prolyl-L-arginyl-, Octostim, 1-{[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-N~5~-(diaminomethylidene)-D-ornithylglycinamide, (1-Deamino-8-D-Arg)-vasopressin, [1-β-Mercaptopropionic acid-8-D-arginine]vasopressin, [Deamino1-D-arginine8]vasopressin, [Desamino-Cys1,D-Arg8]vasopressin, 1-(3-Mercaptopropionic acid)-8-D-arginine-vasopressin, 1: PN: US20020013262 PAGE: 2 claimed protein, 1-Deamino-[8-D-arginine]vasopressin, 1-Deamino-1-[D-Arg8]-vasopressin, 1-Desamino-8-D-arginine-vasopressin, 1-Desaminocystine-8-D-arginine-vasopressin, 45: PN: WO2005000360 SEQID: 40 claimed protein, 8-D-Arginine deaminovasopressin, Adiuretin, Adiuretin SD, DAV Ritter, Ddavp, Desmopresina, Desmopressine, Desmospray, Glycinamide, N-(3-mercapto-1-oxopropyl)-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-D-arginyl-, cyclic (1→5)-disulfide, Minirin, Minrin, Peptide, (Xaa-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly), ?, Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-, Vasopressin, 1-(3-mercaptopropionic acid)-8-D-arginine-
• CAS: 16679-58-6

Description

Desmopressin is a synthetic analog of the natural hormone arginine vasopressin. It has been shown to be effective in the treatment of primary nocturnal enuresis, and a number of studies have reported that desmopressin is an effective therapy for idiopathic nocturnal enuresis. Desmopressin also has effects on water permeability, hemolysis, and protein synthesis. It increases the concentration of camp levels in urine and plasma while also inhibiting erythrocyte aggregation. Desmopressin has been shown to be more effective than placebo in women with primary nocturnal enuresis.

• Brand: Biosynth

Chemical properties

• Molecular weight: 1,069.22 g/mol
• Formula: C₄₆H₆₄N₁₄O₁₂S₂
• Purity: Min. 95%
• Color/Form: Powder